Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

795 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).
Pinter A, Eyerich K, Costanzo A, Garrelts A, Schuster C, Mert C, Lampropoulou A, Fotiou K, Maul JT, Papp KA. Pinter A, et al. Among authors: costanzo a. J Dermatolog Treat. 2024 Dec;35(1):2350227. doi: 10.1080/09546634.2024.2350227. Epub 2024 May 26. J Dermatolog Treat. 2024. PMID: 38797734
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis).
Valenti M, Gargiulo L, Ibba L, Malagoli P, Amoruso F, Balato A, Bardazzi F, Burlando M, Carrera CG, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Maurelli M, Megna M, Orsini D, Travaglini M, Costanzo A, Narcisi A. Valenti M, et al. Among authors: costanzo a. Dermatol Ther (Heidelb). 2024 May 15. doi: 10.1007/s13555-024-01182-4. Online ahead of print. Dermatol Ther (Heidelb). 2024. PMID: 38748344
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting.
Alulis S, Bernardini N, Burlando M, Costanzo A, Francesa Morel PC, Gisondi P, Loconsole F, Megna M, Pellacani G, Piaserico S, Prignano F, Secchi O, Skroza N, Hassan F. Alulis S, et al. Among authors: costanzo a. Dermatol Ther (Heidelb). 2024 May;14(5):1273-1291. doi: 10.1007/s13555-024-01170-8. Epub 2024 May 10. Dermatol Ther (Heidelb). 2024. PMID: 38727995 Free PMC article.
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals.
Paolino G, Narcisi A, Carugno A, Malagoli P, Di Nicola MR, Foti A, Bianchi VG, Locatelli AG, Sena P, Costanzo A, Mercuri SR, Valenti M. Paolino G, et al. Among authors: costanzo a. J Dermatolog Treat. 2024 Dec;35(1):2351489. doi: 10.1080/09546634.2024.2351489. Epub 2024 May 9. J Dermatolog Treat. 2024. PMID: 38724042 Free article.
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Cascio Ingurgio R, Malagoli P, Amoruso F, Balato A, Bardazzi F, Brianti P, Brunasso G, Burlando M, Cagni AE, Caproni M, Carrera CG, Carugno A, Caudullo F, Cuccia A, Dapavo P, Di Brizzi EV, Dini V, Gaiani FM, Gisondi P, Guarneri C, Lasagni C, Licata G, Loconsole F, Marzano AV, Megna M, Mercuri SR, Musumeci ML, Orsini D, Ribero S, Ruffo Di Calabria V, Satolli F, Strippoli D, Travaglini M, Trovato E, Venturini M, Zichichi L, Valenti M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: costanzo a. J Dermatolog Treat. 2024 Dec;35(1):2350760. doi: 10.1080/09546634.2024.2350760. Epub 2024 May 7. J Dermatolog Treat. 2024. PMID: 38714323 Free article.
795 results